The European Medicines Agency (EMA) and the U.S. FDA’s Dr. Peter Marks co-chaired a meeting with international regulators who published a report on January 21, 2022, highlighting their discussions on the effectiveness of current vaccines against the SARS-CoV-2 betacoronavirus Omicron variant.
Upon reviewing data on the impact of Omicron, the meeting participants concluded that current vaccines offer less protection against infection and mild disease caused by this coronavirus variant.
Read More
